Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Home
Store
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Overview of the Safety of Citalopram
$
30.00
Add to cart
Details
Laura Cousino Klein, PhD: Smoking Abstinence Impairs Time Estimation Accuracy in Cigarette Smokers
$
30.00
Add to cart
Details
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
$
30.00
Add to cart
Details
Nunzio Pomara, MD: Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
$
30.00
Add to cart
Details
Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
$
30.00
Add to cart
Details
Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder
$
30.00
Add to cart
Details
The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines
$
30.00
Add to cart
Details
Cognitive Behavioral Approaches to the Treatment of Pain
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
$
30.00
Add to cart
Details
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
$
30.00
Add to cart
Details
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
$
30.00
Add to cart
Details
Pharmacology of Valproate
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Innovative Treatment Strategies With Anticonvulsants: A Focus on Bipolar Disorder
$
10.00
Add to cart
Details
Generalized Anxiety Disorder – A Doctor’s Guide
$
15.00
Add to cart
Details
Atypical Anti psychotic Drugs – A Doctor’s Guide
$
15.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Amisulpride for Clozapine Induced Sialorrhea
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Antipsychotic Treatment of Autistic Shutdowns—A Case Study
$
30.00
Add to cart
Details
Challenges in Transitioning from Methadone to Buprenorphine- Naloxone for Chronic Pain Management: Two Cases
$
30.00
Add to cart
Details
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood
$
30.00
Add to cart
Details
Akinetic Mutism Following Bilateral Infarcts Associated with a Mitral Valve Papillary Fibroelastoma
$
30.00
Add to cart
Details
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
$
30.00
Add to cart
Details
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
$
30.00
Add to cart
Details
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
$
30.00
Add to cart
Details
Trends in Outpatient Buprenorphine Prescribing for Chronic Pain: A Retrospective Analysis Over 18 Months
$
30.00
Add to cart
Details
Before Attributing Catatonia to Autism with Anxiety, All Other Causes should be Carefully Excluded, Especially in a Patient with Meningioma
$
30.00
Add to cart
Details
Psychopharmacology: The ‘Combo Pills’-Did it find its way into Practice?
$
30.00
Add to cart
Details
Previous
1
…
7
8
9
…
15
Next
Page load link
Go to Top
